243 related articles for article (PubMed ID: 29914847)
21. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
[TBL] [Abstract][Full Text] [Related]
22. Could vaccination against Neisseria gonorrhoeae be on the horizon?
Russell MW
Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
[No Abstract] [Full Text] [Related]
23. Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review.
Russell MW; Hedges SR; Wu HY; Hook EW; Mestecky J
Am J Reprod Immunol; 1999 Jul; 42(1):58-63. PubMed ID: 10429768
[TBL] [Abstract][Full Text] [Related]
24. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
Baarda BI; Zielke RA; Holm AK; Sikora AE
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
[TBL] [Abstract][Full Text] [Related]
26. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.
Hedges SR; Mayo MS; Mestecky J; Hook EW; Russell MW
Infect Immun; 1999 Aug; 67(8):3937-46. PubMed ID: 10417159
[TBL] [Abstract][Full Text] [Related]
27. Immunity in infection with Neisseria gonorrhoeae: duration and serological response in the chimpanzee.
Arko RJ; Duncan WP; Brown WJ; Peacock WL; Tomizawa T
J Infect Dis; 1976 Apr; 133(4):441-7. PubMed ID: 816974
[TBL] [Abstract][Full Text] [Related]
28. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae.
Kasper DL; Rice PA; McCormick WM
J Infect Dis; 1977 Feb; 135(2):243-51. PubMed ID: 402426
[TBL] [Abstract][Full Text] [Related]
29. Gonococcal microparticle vaccine in dissolving microneedles induced immunity and enhanced bacterial clearance in infected mice.
Bagwe P; Bajaj L; Menon I; Braz Gomes K; Kale A; Patil S; Vijayanand S; Gala R; D'Souza MJ; Zughaier SM
Int J Pharm; 2023 Jul; 642():123182. PubMed ID: 37369287
[TBL] [Abstract][Full Text] [Related]
30. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
Edwards JL; Jennings MP; Apicella MA; Seib KL
Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
[TBL] [Abstract][Full Text] [Related]
31. Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae.
So NS; Ostrowski MA; Gray-Owen SD
J Immunol; 2012 Apr; 188(8):4008-22. PubMed ID: 22427638
[TBL] [Abstract][Full Text] [Related]
32. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
33. Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae.
Plante M; Jerse A; Hamel J; Couture F; Rioux CR; Brodeur BR; Martin D
J Infect Dis; 2000 Sep; 182(3):848-55. PubMed ID: 10950780
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function.
Ngampasutadol J; Rice PA; Walsh MT; Gulati S
Vaccine; 2006 Jan; 24(2):157-70. PubMed ID: 16125281
[TBL] [Abstract][Full Text] [Related]
35. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
36. Bacterial ghosts are an efficient delivery system for DNA vaccines.
Ebensen T; Paukner S; Link C; Kudela P; de Domenico C; Lubitz W; Guzmán CA
J Immunol; 2004 Jun; 172(11):6858-65. PubMed ID: 15153504
[TBL] [Abstract][Full Text] [Related]
37. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
Francis IP; Lui X; Wetzler LM
Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
[TBL] [Abstract][Full Text] [Related]
38. Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.
Thomas CE; Zhu W; Van Dam CN; Davis NL; Johnston RE; Sparling PF
Infect Immun; 2006 Mar; 74(3):1612-20. PubMed ID: 16495532
[TBL] [Abstract][Full Text] [Related]
39. Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines.
Baarda BI; Martinez FG; Sikora AE
Front Immunol; 2018; 9():2793. PubMed ID: 30564232
[TBL] [Abstract][Full Text] [Related]
40. Preliminary studies on the development of a gonococcal vaccine.
Greenberg I; Diena BB; Kenny CP; Znamirowski R
Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
